Trials / Completed
CompletedNCT05621447
A Mass Balance Study of [14C] TAS-303 in Healthy Adult Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Taiho Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the pharmacokinetics, mass balance recovery, metabolite profile and metabolite identification of \[14C\]TAS-303 following oral single dose
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TAS-303, [14C]TAS-303 | oral administration on day 1 |
Timeline
- Start date
- 2022-09-07
- Primary completion
- 2022-11-03
- Completion
- 2023-02-22
- First posted
- 2022-11-18
- Last updated
- 2023-08-07
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT05621447. Inclusion in this directory is not an endorsement.